Evidence map›Paper›PMID 38288543›Full record

ReviewJournal of Korean medical science2024

Antibiotic Resistance of

Md Hasanuzzaman, Chang Seok Bang, Eun Jeong Gong

Abstract readReview
In one paragraph

Review in Journal of Korean medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Some Newer Antibiotics Active AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  7. Low-Abundance and FragmentaryBiomolecules · 2026
    Article
  8. Article
  9. Levofloxacin and Rifampin Resistance inAntibiotics (Basel, Switzerland) · 2026
    Article
  10. Beyond Antibiotics: Alternative Strategies TargetingExpert reviews in molecular medicine · 2026
    Review
  11. Treatment of Helicobacter pylori Infection in Korea: An Evidence-Based Analysis of the Upcoming 2025 Guideline.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Review
  12. Article
  13. Genomic characterization and biological activities of cell-free supernatant fromFrontiers in cellular and infection microbiology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Resistance reversal: Taiwan'sWorld journal of gastroenterology · 2025
    Article
  18. Article
  19. BeyondMedicina (Kaunas, Lithuania) · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Md Hasanuzzaman *Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.ORCID https://orcid.org/0000-0001-7132-3921
Chang Seok Bang *Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.ORCID https://orcid.org/0000-0003-4908-5431
Eun Jeong GongDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea. gej@hallym.ac.kr.ORCID https://orcid.org/0000-0003-3996-3472

Funding

Hallym UniversityNational Research Foundation of Korea NRF-2021R1C1C1010631
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal DiseasesHelicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsDrug Resistance, MicrobialHumansAnti-Bacterial AgentsAntibiotic ResistanceAntimicrobial StewardshipHelicobacter pyloriMultidrug Resistance

Identifiers

PMID38288543
PMCPMC10825452

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.